Corrigendum to “Chronic respiratory diseases as a risk factor for herpes zoster infection” [Arch Bronconeumol. 2024;59(12):797–804]

Morena, Diego; Lumbreras, Sara; Rodríguez, José Miguel; Campos, Carolina; Castillo, María; Benavent, María; Izquierdo, José Luis

doi:10.1016/j.arbres.2024.05.016

Archivos de Bronconeumología

ISSN: 0300-2896

Archivos de Bronconeumologia is an international journal that publishes original studies whose content is based upon results of research initiatives dealing with several aspects of respiratory medicine including epidemiology, respiratory physiology, pathophysiology of respiratory diseases, clinical management, thoracic surgery, pediatric lung diseases, respiratory critical care, respiratory allergy and basic research. Other types of articles such as editorials, reviews, and different types of letters are also published in the journal. Additionally, the journal expresses the voice of the following scientific societies: the Spanish Respiratory Society of Pneumology and Thoracic Surgery (SEPAR; https://www.separ.es/), the Latin American Thoracic Society (ALAT; https://alatorax.org/), and the Iberian American Association of Thoracic Surgery (AIACT; http://www.aiatorax.com/).

It is a monthly journal in which all manuscripts are sent to peer-review and handled by the editor or an associate editor from the team and the final decision is made on the basis of the comments from the expert reviewers and the editors. The journal is published solely in English. All the published data is composed of novel manuscripts not previously published in any other journal and not being in consideration for publication in any other journal..

The journal is indexed at Science Citation Index Expanded, Medline/Pubmed, Embase and SCOPUS. Access to any published article is possible through the journal's web page as well as from Pubmed, ScienceDirect, and other international databases. Furthermore, the journal is also present in X, Facebook and Linkedin. Manuscripts can be submitted electronically using the following web site: https://www.editorialmanager.com/ARBR/.

Indexed in:

Current Contents/Clinical Medicine, JCR SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, SCOPUS, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

8.7

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

3.5

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.464

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.482

View more metrics

Open Access Option

Journal Information

Previous article | Next article

Vol. 60. Issue 8.

Pages 539-540 (August 2024)

Export reference

Download PDF

Arch Bronconeumol. 2023;59:797-80410.1016/j.arbres.2023.08.010

Diego Morena, Sara Lumbreras, José Miguel Rodríguez, Carolina Campos, María Castillo, María Benavent, José Luis Izquierdo

This item has received

612 Visits

Article information

Full Text

Download PDF

Statistics

Tables (2)

Table 5. Main non-respiratory comorbidities, defined as risk factors, and their prevalence in the population with herpes zoster, with and without PHN.

Table 6. Main respiratory pathologies and their prevalence in the population with herpes zoster, with and without PHN.

Show moreShow less

Full Text

In the paper “Chronic respiratory diseases as a risk factor for herpes zoster infection” (D. Morena, S. Lumbreras, J.M. Rodríguez et al. Archivos de Bronconeumología 59 (2023) 797–804), errors have been detected in Tables 5 and 6, so we are reproducing them as they should have been published.

Table 5.

Main non-respiratory comorbidities, defined as risk factors, and their prevalence in the population with herpes zoster, with and without PHN.

	Herpes zoster	%	Postherpetic neuralgia	%	No postherpetic neuralgia	%	P	OR (95%)
Arterial hypertension
Yes	16867	53.1	1501	8.9	15366	91.1	<0.001	1.2 (1.1–1.3)
No	14898	46.9	1175	7.9	13723	92.1

Dyslipidemia
Yes	12547	39.5	1167	9.3	11380	90.7	<0.001	1.2 (1.1–1.3)
No	19218	60.5	1509	7.9	17709	92.1

Diabetes mellitus
Yes	8417	26.5	976	11.6	7441	88.4	<0.001	1.7 (1.5–1.8)
No	23348	73.5	1700	7.3	21648	92.7

Depression
Yes	5802	18.3	604	10.4	5198	89.6	<0.001	1.3 (1.2–1.4)
No	25963	81.7	2072	8.0	23891	92.0

Ischemic heart disease
Yes	3691	11.6	207	5.6	3484	94.4	<0.001	0.6 (0.5–0.7)
No	28074	88.4	2469	8.8	25605	91.2

Rheumatoid arthritis
Yes	602	1.9	77	12.8	525	87.2	<0.001	1.6 (1.3–2.1)
No	31163	98.1	2599	8.3	28564	91.7

Inflammatory bowel disease
Yes	450	1.4	33	7.3	417	92.7	>0.05	0.9 (0.6–1.2)
No	31315	98.6	2643	8.4	28672	91.6

Stroke
Yes	2673	8.4	328	12.3	2345	87.7	<0.001	1.6 (1.4–1.8)
No	29092	91.6	2348	8.1	26744	91.9

Osteoporosis
Yes	3262	10.3	410	12.5	2852	87.5	<0.001	1.7 (1.5–1.9)
No	28503	89.7	2266	8.0	26237	92.0

Table 6.

Main respiratory pathologies and their prevalence in the population with herpes zoster, with and without PHN.

	Herpes zoster	%	Postherpetic neuralgia	%	No postherpetic neuralgia	%	P	OR (95%)
Asthma
Yes	2497	7.9	231	9.3	2266	90.7	>0.05	1.1 (0.9–1.3)
No	29268	92.1	2445	8.4	26823	91.6

COPD
Yes	2784	8.8	386	13.9	2398	86.1	<0.001	1.9 (1.7–2.1)
No	28981	91.2	2290	7.9	26691	92.1

OSA
Yes	2174	6.8	252	11.6	1922	88.4	<0.001	1.5 (1.3–1.7)
No	29591	93.2	2424	8.2	27167	91.8

Lung cancer
Yes	488	1.5	59	12.1	429	87.9	<0.001	1.5 (1.1–1.9)
No	31277	98.5	2617	8.4	28660	91.6